- Home
- EWCZ vs ABSI Comparison
EWCZ vs ABSI Comparison
Compare EWCZ & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.71
HOLD
Current Price
$3.59
Company Overview
Basic Information| Metric | EWCZ | ABSI |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.5M | 577.4M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EWCZ | ABSI |
|---|---|---|
| Price | $3.71 | $3.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $5.50 | ★ $7.98 |
| AVG Volume (30 Days) | 331.6K | ★ 3.9M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.45 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $211,264,000.00 | $2,815,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | $1.62 | $437.79 |
| P/E Ratio | $14.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.72 | $2.01 |
| 52 Week High | $7.60 | $6.33 |
Technical Indicators
Market Signals| Indicator | EWCZ | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 53.17 |
| Support Level | $3.52 | $3.37 |
| Resistance Level | $3.72 | $3.79 |
| Average True Range (ATR) | 0.16 | 0.25 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 22.22 | 34.51 |
Price Performance
Historical Comparison EWCZ
ABSI
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.